Dr. Miele Cosmed Group S.A.

WSE:DMG Stock Report

Market Cap: zł468.1m

Dr. Miele Cosmed Group Valuation

Is DMG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Share Price vs Fair Value

What is the Fair Price of DMG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Discounted Cash Flow
Simply Wall St
zł8.56
Fair Value
37.3% undervalued intrinsic discount
0
Number of Analysts

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DMG?

Key metric:

The above table shows the Price to Earnings ratio for DMG. This is calculated by dividing DMG's market cap by their current earnings.
What is DMG's PE Ratio?
PE Ratio13x
Earningszł35.95m
Market Capzł468.14m

Price to Earnings Ratio vs Peers

How does DMG's PE Ratio compare to its peers?

The above table shows the PE ratio for DMG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average13.2x
4MS 4MASS Spólka Akcyjna
9.5xn/azł172.6m
A092730 NeoPharm
7.4x15.1%₩164.9b
A234690 GREEN CROSS WellBeing
23.4xn/a₩156.9b
S&J S & J International Enterprises
12.4xn/a฿4.8b
DMG Dr. Miele Cosmed Group
13xn/azł468.1m

Price to Earnings Ratio vs Industry

How does DMG's PE Ratio compare vs other companies in the European Personal Products Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
DMG 13.0xIndustry Avg. 23.6xNo. of Companies4PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price to Earnings Ratio vs Fair Ratio

What is DMG's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DMG PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio13x
Fair PE Ration/a

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/24 19:45
End of Day Share Price 2025/01/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dr. Miele Cosmed Group S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution